Works matching IS 14363291 AND DT 2019 AND VI 22 AND IP 4


Results: 30
    1
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 4, p. 742, doi. 10.1007/s10120-019-00926-y
    By:
    • Yoshida, Takashi;
    • Yamaguchi, Tatsuya;
    • Maekawa, Shinya;
    • Takano, Shinichi;
    • Kuno, Toru;
    • Tanaka, Keisuke;
    • Iwamoto, Fumihiko;
    • Tsukui, Yuya;
    • Kobayashi, Shoji;
    • Asakawa, Yukiko;
    • Shindo, Hiroko;
    • Fukasawa, Mitsuharu;
    • Nakayama, Yasuhiro;
    • Inoue, Taisuke;
    • Uetake, Tomoyoshi;
    • Ohtaka, Masahiko;
    • Sato, Tadashi;
    • Mochizuki, Kunio;
    • Enomoto, Nobuyuki
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 4, p. 873, doi. 10.1007/s10120-018-00919-3
    By:
    • Shoji, Yoshiaki;
    • Kumagai, Koshi;
    • Kamiya, Satoshi;
    • Ida, Satoshi;
    • Nunobe, Souya;
    • Ohashi, Manabu;
    • Yoshimizu, Shoichi;
    • Horiuchi, Yusuke;
    • Yoshio, Toshiyuki;
    • Ishiyama, Akiyoshi;
    • Hirasawa, Toshiaki;
    • Osako, Tomo;
    • Yamamoto, Noriko;
    • Fujisaki, Junko;
    • Sano, Takeshi;
    • Hiki, Naoki
    Publication type:
    Article
    18
    19

    Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 4, p. 892, doi. 10.1007/s10120-018-00912-w
    By:
    • Funakoshi, Taro;
    • Miyamoto, Shin'ichi;
    • Kakiuchi, Nobuyuki;
    • Nikaido, Mitsuhiro;
    • Setoyama, Takeshi;
    • Yokoyama, Akira;
    • Horimatsu, Takahiro;
    • Yamada, Atsushi;
    • Torishima, Masako;
    • Kosugi, Shinji;
    • Yamada, Hidetaka;
    • Sugimura, Haruhiko;
    • Haga, Hironori;
    • Sakai, Yoshiharu;
    • Ogawa, Seishi;
    • Seno, Hiroshi;
    • Muto, Manabu;
    • Chiba, Tsutomu
    Publication type:
    Article
    20
    21

    Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 4, p. 828, doi. 10.1007/s10120-018-00909-5
    By:
    • Bang, Yung-Jue;
    • Kang, Yoon-Koo;
    • Catenacci, Daniel V.;
    • Muro, Kei;
    • Fuchs, Charles S.;
    • Geva, Ravit;
    • Hara, Hiroki;
    • Golan, Talia;
    • Garrido, Marcelo;
    • Jalal, Shadia I.;
    • Borg, Christophe;
    • Doi, Toshihiko;
    • Yoon, Harry H.;
    • Savage, Mary J.;
    • Wang, Jiangdian;
    • Dalal, Rita P.;
    • Shah, Sukrut;
    • Wainberg, Zev A.;
    • Chung, Hyun Cheol
    Publication type:
    Article
    22
    23
    24

    Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 4, p. 899, doi. 10.1007/s10120-018-00907-7
    By:
    • Benusiglio, Patrick R.;
    • Colas, Chrystelle;
    • Guillerm, Erell;
    • Canard, Axelle;
    • Delhomelle, Hélène;
    • Warcoin, Mathilde;
    • Bellanger, Jérôme;
    • Eyries, Mélanie;
    • Zizi, Mohamed;
    • Netter, Jeanne;
    • Soubrier, Florent;
    • Parc, Yann;
    • Mourregot, Anne;
    • Maran Gonzalez, Aurélie;
    • Cusin, Veronica;
    • Denis, Jérôme A.;
    • Coupier, Isabelle;
    • Svrcek, Magali;
    • Coulet, Florence
    Publication type:
    Article
    25
    26
    27

    Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 4, p. 853, doi. 10.1007/s10120-018-0902-2
    By:
    • Hayashi, Shogo;
    • Kanda, Mitsuro;
    • Ito, Seiji;
    • Mochizuki, Yoshinari;
    • Teramoto, Hitoshi;
    • Ishigure, Kiyoshi;
    • Murai, Toshifumi;
    • Asada, Takahiro;
    • Ishiyama, Akiharu;
    • Matsushita, Hidenobu;
    • Tanaka, Chie;
    • Kobayashi, Daisuke;
    • Fujiwara, Michitaka;
    • Murotani, Kenta;
    • Kodera, Yasuhiro
    Publication type:
    Article
    28
    29
    30

    Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 4, p. 817, doi. 10.1007/s10120-018-0903-1
    By:
    • Doi, Toshihiko;
    • Iwasa, Satoru;
    • Muro, Kei;
    • Satoh, Taroh;
    • Hironaka, Shuichi;
    • Esaki, Taito;
    • Nishina, Tomohiro;
    • Hara, Hiroki;
    • Machida, Nozomu;
    • Komatsu, Yoshito;
    • Shimada, Yasuhiro;
    • Otsu, Satoshi;
    • Shimizu, Shin;
    • Watanabe, Morihiro
    Publication type:
    Article